Adaptive beta-Cell Neogenesis in the Adult Mouse in Response to Glucocorticoid-Induced Insulin Resistance (Équipe Fève)

01 - Janvier - 2019

Emilie Courty, Adrien Besseiche, Thi Thu Huong Do, Alexandrine Liboz, Fatima Mohamed Aguid, Evans Quilichini, Melissa Buscato, Pierre Gourdy, Jean-François Gautier, Jean-Pierre Riveline, Cécile Haumaitre, Marion Buyse, Bruno Fève, Ghislaine Guillemain, Bertrand Blondeau

Diabetes. 2019;68(1):95-108

Both type 1 and type 2 diabetes are characterized by deficient insulin secretion and decreased beta-cell mass. Thus, regenerative strategies to increase beta-cell mass need to be developed. To characterize mechanisms of beta-cell plasticity, we studied a model of severe insulin resistance in the adult mouse and defined how beta-cells adapt. Chronic corticosterone (CORT) treatment was given to adult mice and led to rapid insulin resistance and adaptive increased insulin secretion. Adaptive and massive increase of beta-cell mass was observed during treatment up to 8 weeks. beta-Cell mass increase was partially reversible upon treatment cessation and reinduced upon subsequent treatment. beta-Cell neogenesis was suggested by an increased number of islets, mainly close to ducts, and increased Sox9 and Ngn3 mRNA levels in islets, but lineage-tracing experiments revealed that neoformed beta-cells did not derive from Sox9- or Ngn3-expressing cells. CORT treatment after beta-cell depletion partially restored beta-cells. Finally, beta-cell neogenesis was shown to be indirectly stimulated by CORT because serum from CORT-treated mice increased beta-cell differentiation in in vitro cultures of pancreatic buds. Altogether, the results present a novel model of beta-cell neogenesis in the adult mouse and identify the presence of neogenic factors in the serum of CORT-treated mice.

2019 Diabetes - Courty (fig).jpg

Hôpital St-Antoine

Bâtiment Kourilsky
34 rue Crozatier
75012 PARIS

Sorbonne Université
27 rue Chaligny
75012 PARIS

Ce site utilise des cookies et vous donne le contrôle sur ce que vous souhaitez activer Tout accepter Personnaliser